A citation-based method for searching scientific literature

Kristin Bergethon, Alice T Shaw, Sai-Hong Ignatius Ou, Ryohei Katayama, Christine M Lovly, Nerina T McDonald, Pierre P Massion, Christina Siwak-Tapp, Adriana Gonzalez, Rong Fang, Eugene J Mark, Julie M Batten, Haiquan Chen, Keith D Wilner, Eunice L Kwak, Jeffrey W Clark, David P Carbone, Hongbin Ji, Jeffrey A Engelman, Mari Mino-Kenudson, William Pao, A John Iafrate. J Clin Oncol 2012
Times Cited: 1002



Manabu Soda, Young Lim Choi, Munehiro Enomoto, Shuji Takada, Yoshihiro Yamashita, Shunpei Ishikawa, Shin-ichiro Fujiwara, Hideki Watanabe, Kentaro Kurashina, Hisashi Hatanaka, Masashi Bando, Shoji Ohno, Yuichi Ishikawa, Hiroyuki Aburatani, Toshiro Niki, Yasunori Sohara, Yukihiko Sugiyama, Hiroyuki Mano. Nature 2007
Times Cited: 3578




List of shared articles



Times cited

From Tissue-Agnostic to N-of-One Therapies: (R)Evolution of the Precision Paradigm.
Jacob J Adashek, Vivek Subbiah, Razelle Kurzrock. Trends Cancer 2021
14


Real World Characterization of Advanced Non-Small Cell Lung Cancer in Never Smokers by Actionable Mutation Status.
Kathleen Kerrigan, Xuechen Wang, Benjamin Haaland, Blythe Adamson, Shiven Patel, Sonam Puri, Wallace Akerley. Clin Lung Cancer 2021
0

Implementation of clinical sequencing for molecular profiling in patients with advanced cancer.
Tomoya Fukui, Kazuko Sakai, Jiichiro Sasaki, Mikiko Ishihara Kakegawa, Satoshi Igawa, Hisashi Mitsufuji, Masayuki Takeda, Takayuki Takahama, Kazuhiko Nakagawa, Kazuto Nishio,[...]. Cancer Biomark 2021
0


Monitoring and Managing Lorlatinib Adverse Events in the Portuguese Clinical Setting: A Position Paper.
Fernando Barata, Carlos Aguiar, Tiago Reis Marques, José Bravo Marques, Venceslau Hespanhol. Drug Saf 2021
0

Cancer Etiology and Prevention Principle: "1 + X".
Hui Liu, Zigang Dong. Cancer Res 2021
0

A Novel Tool for the Risk Assessment and Personalized Chemo-/Immunotherapy Response Prediction of Adenocarcinoma and Squamous Cell Carcinoma Lung Cancer.
Hai Chen, Xianquan Xu, Tengfei Ge, Congshu Hua, Xiaodong Zhu, Qikui Wang, Zaicheng Yu, Renquan Zhang. Int J Gen Med 2021
0

Anaplastic lymphoma kinase rearrangement prevalence in patients with advanced non-small cell lung cancer in the United States: retrospective real world data.
Timothy Craig Allen, Yan Xiao, Baiyu Yang, Denise Croix, Anup Abraham, Stella Redpath, Julia Engstrom-Melynk, Roma Shah, Jaya Madala, Eric H Bernicker. Oncotarget 2021
0

Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
Vinayak Palve, Yi Liao, Lily L Remsing Rix, Uwe Rix. Semin Cancer Biol 2021
7

Mechanisms of drug resistance mediated by long non-coding RNAs in non-small-cell lung cancer.
Manuela La Montagna, Lucy Ginn, Michela Garofalo. Cancer Gene Ther 2021
1

Clinical Characteristics, Treatments, and Concurrent Mutations in Non-Small Cell Lung Cancer Patients With NF1 Mutations.
Lee Bowman, Ramon Tiu, Emily Nash Smyth, Melinda Dale Willard, Li Li, Julie Beyrer, Yimei Han, Ambrish Singh. Clin Lung Cancer 2021
2


Different clinical features between patients with ROS1-positive and ALK-positive advanced non-small cell lung cancer.
Xianxiu Ji, Huikang Xie, Ren Zhu, Bin Chen, Sen Jiang, Jie Luo. J Int Med Res 2021
0

Immunocytochemical Detection of ALK and ROS1 Rearrangements in Lung Cancer Cytological Samples.
Diane Frankel, Elise Kaspi, Patrice Roll. Methods Mol Biol 2021
0

Proteomic analysis of tyrosine phosphorylation induced by exogenous expression of oncogenic kinase fusions identified in lung adenocarcinoma.
Sebastian A Wagner, Pawel P Szczesniak, Andrea Voigt, Justus F Gräf, Petra Beli. Proteomics 2021
0

Updates in the molecular pathology of non-small cell lung cancer.
Elizabeth Paver, Sandra O'Toole, Xin Min Cheng, Annabelle Mahar, Wendy A Cooper. Semin Diagn Pathol 2021
0

Lung cancer.
Alesha A Thai, Benjamin J Solomon, Lecia V Sequist, Justin F Gainor, Rebecca S Heist. Lancet 2021
8


Immunotherapy in oncogene addicted non-small cell lung cancer.
Luke McLean, Jose Luis Leal, Benjamin J Solomon, Thomas John. Transl Lung Cancer Res 2021
1

First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly.
Tania Losanno, Cesare Gridelli. Curr Oncol Rep 2021
0

TNK1 is a ubiquitin-binding and 14-3-3-regulated kinase that can be targeted to block tumor growth.
Tsz-Yin Chan, Christina M Egbert, Julia E Maxson, Adam Siddiqui, Logan J Larsen, Kristina Kohler, Eranga Roshan Balasooriya, Katie L Pennington, Tsz-Ming Tsang, Madison Frey,[...]. Nat Commun 2021
1

Current Landscape of Non-Small Cell Lung Cancer: Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy.
Olga Rodak, Manuel David Peris-Díaz, Mateusz Olbromski, Marzenna Podhorska-Okołów, Piotr Dzięgiel. Cancers (Basel) 2021
3

Recent advances in lung cancer genomics: Application in targeted therapy.
Neha Pathak, Sindhura Chitikela, Prabhat Singh Malik. Adv Genet 2021
1

Immunotherapy in Non-Small Cell Lung Cancer With Actionable Mutations Other Than EGFR.
Karan Seegobin, Umair Majeed, Nathaniel Wiest, Rami Manochakian, Yanyan Lou, Yujie Zhao. Front Oncol 2021
0

Precision Management of Advanced Non-Small Cell Lung Cancer.
Ching-Yao Yang, James Chih-Hsin Yang, Pan-Chyr Yang. Annu Rev Med 2020
30

Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing.
Danielle Cohen, Liesbeth M Hondelink, Nienke Solleveld-Westerink, Sandra M Uljee, Dina Ruano, Anne-Marie Cleton-Jansen, Jan H von der Thüsen, S Rajen S Ramai, Pieter E Postmus, Jacob F Graadt van Roggen,[...]. J Thorac Oncol 2020
26